![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Drug Delivery ![]() Related Tags Cardiovascular
Demand Forecast Drug Development Drugs Formulation Healthcare Market Market Forecast Market Growth Market Leaders Market Report Market Research Reports Market Share Market Size Medical Nanotechnology Pharma Report Research Technology
| drug delivery News+ XML/RSSBy Frost & Sullivan Participants shape research measuring perceptions and expectations for pharmaceutical drug delivery technologies By SMi Group Examining the latest developments in nanomedicine and enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics. By Arrowhead Publishers and Conferences FDA's Lead Reviewer for DONED to Give Regulatory Perspective on Development & Validation of Diagnostic Devices for Traumatic Brain Injury at 2nd Annual TBI Conference By SMi Group Overcome Formulation challenges for oral delivery of peptide and lipid-based therapeutics By BCC Research The global market for advanced drug delivery systems is estimated to reach nearly $137.9 billion in 2011 and $175.6 billion by 2016 at a compound annual growth rate (CAGR) of 5%. By Bharat Book Bharatbook added a new report on " Antibacterial Drugs: World Market Prospects 2012-2022 " which gives an overview, Demand, Supply Trends and industry analysis reports. By SMi Group How to select the most apporpriate formulation tool for poorly soluble drugs By Rajesh Gunnam The Global Drug Delivery Device Market is Forecast to Reach $22 Billion in 2017 By Dave Karasic, J.D. The Boston-area formulation development CRO Integral BioSystems, LLC announces tradeshow presence at key pharmaceutical and biotech conferences, as part of its strategy to increase visibility. By Masha Skvirtchak We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area. By Insight Pharma Reports Strategic business intelligence by CHI's Insight Pharma Reports: Drug Delivery Technologies: Drug Reformulations and Administration Routes Available at InsightPharmaReports.com By Insight Pharma Reports Insight Pharma Reports Announces 2011 Report Titles By Arrowhead Publishers and Conferences Arrowhead’s Annual Traumatic Brain Injury Conference, set to take place on March 7, 2011 in Washington, DC has been organized to discuss the challenges and opportunities of development and commercialization of new therapies for TBI. By Johanna Haynes Survey finds future of drug delivery for inflammatory diseases is in the oral therapeutic market By Bharatbook Bharatbook.com added a new report on "Insulin Delivery Devices Market Analysis and Future Forecast" into its market report catalogue for reselling By Rajesh Gunnam The Nano-Enabled Market Represents Significant Opportunities and High Level of Unmet Needs By Jayme Porkolab, The Global Leaders The Global Leaders will be a sponsor of The Conference Forum's premier event, “New Paradigms to Fund and Manage Product Development for Biotech, Drug Delivery and Small Pharma” - January 13-14, 2011 at the Westin San Francisco Market Street. By Vindico NanoBioTechnology, Inc. The National Heart, Lung and Blood Institute and KY Cabinet for Economic Development Combine for $299,683 in Awards to Lexington, KY-based Company By Bharatbook Bharatbook added a new report on "Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators" into its market report catalogue for reselling. By Visiongain Ltd. Our new report shows you trends to watch. Novel and generic drug producers can benefit from emerging and established drug delivery technologies. By Bharatbook Bharatbook.com announces the inclusion of latest conference on "Conference on Clinical Trials Asia Summit 2010 " conference to be held at 19, 20, August 2010, Taj Residency (M.G. Road), Bangalore, India By Aciont Inc Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®” By Dan Dunlop Dr. Craig J. Davies-Cutting will deliver a presentation titled, “Considerations and Approaches for Filling Dry Powder Inhalers (DPIs)” at the Management Forum Conference on Dry Powder Inhalers in London, UK. By Action on Smoking and Health (AH) The Food and Drug Administration [FDA] is considering whether to ban the sale of e-cigarettes advertised to administer marijuana to users "at the office, or even on the plane" and with ads suggesting use to get high in public without being detected. By Vindico NanoBioTechnology, Inc. Vindico receives a highly competitive grant from the Gates Foundation in the fourth funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold ways to improve health in developing countries. By Ponsus Pharma Ponsus Pharma signs an exclusive product distribution agreement with Vitaflo Scandinavia AB for Proderm Hud in Sweden, Denmark, Finland and Norway By GlobalData Needle Free Injection Systems, Market Overview By Aciont Inc The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. By Jonna Dagliden Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing drug delivery in central nervous system diseases. By Jonna Dagliden Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing the drug delivery partnering agreements in pharma and biotech. By Lars Blak Ponsus Pharma recruits Mats Silvander, Ph.D. as Research & Development Manager and Dan Johansson, M.Sc. as Sales & Marketing Manager By World Trade Group Dates: 26th – 27th January 2010 Location: Radisson BLU Scandinavia Hotel, Dusseldorf, Germany. Major biotech and pharma players will gather, in Dusseldorf, to discuss drug delivery and formulation By MarketsandMarkets The entire market for top ten medical device technologies is estimated to be approximately $454.3 billion, of which medical diagnostic devices technologies alone constitute about 40%. By reports.research.com Global Research & Data Services has published nine reports concerning the healthcare market in China. By Global Research & Data Services The Chinese market for medical devices and equipment has been growing strongly in recent years. The boom is predicted to continue in the future and there are some major opportunities for foreign companies in the Chinese healthcare sector. By Integral Biosystems, LLC Boston area based CRO Integral BioSystems, LLC announces its Drug Development and IP Services to the Biotech community. By Drug Delivery.ca Swine Flu may possibly spread fast across the globe; we investigate the potential pandemic it may cause. We also delve into the Pandemic Phase levels. By Piribo Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering a detailed guide on how to conduct effective deal making in drug delivery. By Piribo Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering a guide to cardiovascular drug delivery. By GlobalData GlobalData's Medical Equipment M&A Trends April 2009 Report is an excellent source providing detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions in the Medical Equipment industry By Marcia Henin An innovative patented Nanotechnology system has been developed by a Drug Development Company located in Israel. This technology has brought the drug development process into a completely new level. By Piribo Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on investment opportunities in drug delivery in Italy. Page:
|
| |||||||||||||||||||||||